BerandaSRPT • NASDAQ
add
Sarepta Therapeutics Inc
$54,63
Setelah Jam Perdagangan Normal:(0,24%)-0,13
$54,50
Tutup: 14 Apr, 17.03.20 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$51,03
Rentang hari
$51,39 - $54,64
Rentang tahun
$48,01 - $173,25
Kapitalisasi pasar
5,30Â M USD
Volume Rata-Rata
2,78Â jt
Rasio P/E
23,36
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 658,41Â jt | 65,94% |
Biaya operasional | 164,47Â jt | 24,17% |
Laba bersih | 159,05Â jt | 248,37% |
Margin laba bersih | 24,16 | 109,90% |
Penghasilan per saham | 1,90 | 131,71% |
EBITDA | 172,14Â jt | 378,20% |
Tarif pajak efektif | 7,39% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,35Â M | -19,18% |
Total aset | 3,96Â M | 21,40% |
Total liabilitas | 2,44Â M | 1,26% |
Total ekuitas | 1,53 M | — |
Saham yang beredar | 97,03 jt | — |
Harga terhadap nilai buku | 3,24 | — |
Tingkat pengembalian aset | 10,69% | — |
Tingkat pengembalian modal | 14,68% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 159,05Â jt | 248,37% |
Kas dari operasi | 92,05Â jt | 268,41% |
Kas dari investasi | 764,12Â jt | 1.287,29% |
Kas dari pembiayaan | 48,99Â jt | 2.421,41% |
Perubahan kas bersih | 905,16Â jt | 873,16% |
Arus kas bebas | 16,42Â jt | 181,63% |
Tentang
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Didirikan
1980
Situs
Karyawan
1.372
